This week is the AAN conference in Seattle. I am sure this is part of the presentation by Opexa at the conference.
http://www.earthtimes.org/articles/s...y,798710.shtml
This is the first positive report and complete report posted by Opexa. It's too bad this news wasn't reported earlier and funding could have been secured to continue with the open label clinical trial.
Too little too late...